Royce & Associates’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-84,855
| Closed | -$685K | – | 1145 |
|
|
2018
Q4 | $685K | Sell |
84,855
-59,145
| -41% | -$477K | 0.01% | 899 |
|
|
2018
Q3 | $1.1M | Hold |
144,000
| – | – | 0.01% | 908 |
|
|
2018
Q2 | $825K | Hold |
144,000
| – | – | 0.01% | 975 |
|
|
2018
Q1 | $687K | Hold |
144,000
| – | – | ﹤0.01% | 1020 |
|
|
2017
Q4 | $707K | Hold |
144,000
| – | – | ﹤0.01% | 1020 |
|
|
2017
Q3 | $755K | Hold |
144,000
| – | – | 0.01% | 998 |
|
|
2017
Q2 | $801K | Hold |
144,000
| – | – | 0.01% | 1002 |
|
|
2017
Q1 | $1.21M | Hold |
144,000
| – | – | 0.01% | 955 |
|
|
2016
Q4 | $912K | Sell |
144,000
-16,000
| -10% | -$101K | 0.01% | 955 |
|
|
2016
Q3 | $706K | Hold |
160,000
| – | – | ﹤0.01% | 966 |
|
|
2016
Q2 | $454K | Hold |
160,000
| – | – | ﹤0.01% | 995 |
|
|
2016
Q1 | $453K | Buy |
+160,000
| New | +$453K | ﹤0.01% | 993 |
|